|
|
|
31.03.26 - 02:36
|
Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting (Business Wire)
|
|
|
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), is pleased to announce that the shareholders of Organigram have overwhelmingly approved the resolution required to consummate the previously announced acquisition by the Company (the “Transaction”) of Sanity Group GmbH (“Sanity Group”) and the related private placement financing (the “Private Placement”) with BT DE Investments Inc., a wholly-owned subsidiary of British American Tobacco (“BAT”) at the Company's annual general and special meeting of shareholders (the “Shareholders”) held on March 30, 2026 (the “Meeting”).
Shareholders approved an ordinary resolution (the “Transaction Resolution”) authorizing (i) the indirect acquisition by the Company of all the issued and outstanding shares of Sanity Group not already owned by the Company, and (ii) the issuance by the Company of up to 96,287,602 common shares to the shareholders of Sanity Group and BAT in connecti...
|
|
|
23.03.26 - 11:06
|
Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH (Business Wire)
|
|
|
ISS Cites Compelling Strategic Rationale, Favorable Market Reaction, and Strong Institutional Confidence in Recommending Shareholders Vote FOR the Transaction ResolutionTORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that Institutional Shareholder Services Inc. ("ISS"), a leading independent proxy advisory firm, has recommended that holders of common shares of Organigram ("Shareholders") vote FOR the ordinary resolution (the "Transaction Resolution") to approve the indirect acquisition of Sanity Group GmbH ("Sanity") at the Company's Annual General and Special Meeting of Shareholders (the "Meeting") to be held on Monday, March 30, 2026, at 10:00 a.m. (Toronto time), at 333 Bay Street, Suite 3400, Toronto, Ontario.
For those Shareholders who are unable to attend the Meeting in person, the Company will make an audio-only teleph...
|
|
|
10.03.26 - 11:03
|
Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting (Business Wire)
|
|
|
Special Meeting to Approve Acquisition of Sanity Group GmbHTORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that it has mailed and filed a management information circular (the “Circular”) and related materials (the “Meeting Materials”) for its annual and special meeting (the “Meeting”) of the holders of its common shares (the “Shareholders”) to be held on March 30, 2026. The Circular is available under Organigram's profile on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov.
In addition to routine annual business to be conducted, Shareholders at the Meeting will be asked to consider and vote upon an ordinary resolution (the “Transaction Resolution”) approving the previously announced proposed acquisition by the Company of all of the issued and outstanding shares (the “Purchased Shares”) of Sanity Group GmbH (“Sanity” or the “Sanity Group”) not a...
|
|
|
|
|
|
|
|
|
|
|
|
|
18.02.26 - 12:06
|
Organigram Announces Proposed Acquisition of Sanity Group, a Leading German Cannabis Company (Business Wire)
|
|
|
Accretive Acquisition of Sanity Group Establishes Organigram as a Global Pure Play Cannabis Company with Leadership Positions in the World's Two Largest Federally Legal Cannabis Markets
Organigram to acquire Sanity Group for up-front consideration of €113.4 million plus a maximum earnout of up to €113.8 million tied to financial performance.
Proposed Acquisition of the Berlin‑based company unites two leaders in the largest federally legal cannabis markets, boosting commercial opportunities, strengthening access to best‑in‑class leadership, and expanding a valuable network of supply-chain partners.
Sanity is achieving top-line growth. Annual net revenue increased from €9 million in 2023 to €60 million in 2025, including €19 million generated in the fourth quarter of 2025.
Sanity Group operates Europe's first two legal cannabis specialty stores as part of scientific pilot projects in Switzerland.
Opportunity to capitalize on Sanity's near-term plans to enter the UK and Poland markets and ...
|
|
|
|
|
|
|
|
|
10.02.26 - 12:03
|
Organigram Reports First Quarter Fiscal 2026 Results (Business Wire)
|
|
|
Strong year-over-year growth supported by Canadian leadership and growing international sales, improving gross margin.TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1, is pleased to announce its results for the first quarter ended December 31, 2025 (“Q1 Fiscal 2026” or "Q1").
Q1 FISCAL 2026 HIGHLIGHTS
Gross Revenue: $97.3 million (+46% year-over-year).
Net Revenue: $63.5 million (+49% year-over-year).
International Revenue: $5.0 million (+51% year-over-year).
Adjusted EBITDA2: $5.3 million (+273% year-over-year).
#1 Market Share in Canada: #1 in vapes, #1 in milled flower, #1 in concentrates, #2 in pre-rolls #3 in edibles, #3 in dried flower1.
U.S. Expansion: Launched Collective Project & Fetch into Illinois and Wisconsin through new distribution partners, expanding US retail footprint to 11 states3.
Powdery Mildew Resistance: Achieved proprietary genetic screening breakthrough t...
|
|
|
|
|
03.02.26 - 12:03
|
Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026 (Business Wire)
|
|
|
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today it will report earnings results for its first quarter fiscal 2026 ended December 31, 2025, on Tuesday, February 10, 2026, prior to market open.
The Company will host a conference call to discuss its results with details as follows:
Date: Tuesday, February 10, 2026
Time: 8:00 am Eastern Time
To register for the conference call, please use this link:
https://events.q4inc.com/analyst/430252525?pwd=WEt2KbHS
To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call. After registering, a confirmation will be sent through email, including dial in details and unique conference call codes for entry. Registration is open through the live call.
To access the webcast:
https://events.q4inc.com/attendee/430252525Participants will receive their details via email....
|
|
|
|
|
|
|
|
|
16.12.25 - 12:06
|
Organigram Reports Record Fourth Quarter and Fiscal 2025 Results (Business Wire)
|
|
|
Record annual revenue, adjusted EBITDA1, and international sales.
TORONTO--(BUSINESS WIRE)--Organigram Global Inc (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 recreational cannabis company by market share2, is pleased to announce record results for the fourth quarter and twelve months ended September 30, 2025 (“Q4 Fiscal 2025” or "Fiscal 2025"). All financial information in this press release is expressed in Canadian dollars ("$").
FOURTH QUARTER 2025 FINANCIAL HIGHLIGHTS
Gross Revenue: $123.3 million (+76% year-over-year).
Net Revenue: $80.1 million (+79% year-over-year).
Adjusted Gross Margin1: $30.6 million or 38%.
Adjusted EBITDA1: $9.8 million (+69% year-over-year).
FISCAL 2025 FINANCIAL HIGHLIGHTS
Gross Revenue: $403.0 million (+63% year-over-year).
Net Revenue: $259.2 million (+62% year-over-year).
Adjusted Gross Margin1: $91.0 million or 35%.
Adjusted EBITDA1: $21.9 million (+160% year-over-year).
FISCAL 2025 COMPANY HIGHLIGHTS
#1 Market S...
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
